ARD-266 is a highly potent and von Hippel-Lindau E3 ligase-based Androgen Receptor ( AR ) PROTAC degrader. ARD-266 effectively induces degradation of AR protein in AR -positive LNCaP, VCaP, and 22Rv1 prostate cancer cell lines with DC 50 values of 0.2-1 nAppearance:SolidIC50& Target:VHLIn Vitro:ARD-266 (Compound 11; 100 nM; 1-24 hours; LNCaP and VCaP cells) treatment effectively reduces the AR protein level within 3 h and achieves near-complete AR elimination with a 6 h treatment in the LNCaP cells. ARD-266 (Compound 11; 1-10000 nM; 24 hourBiological Activity:ARD-266 is a highly potent and von Hippel-Lindau E3 ligase-based Androgen Receptor ( AR ) PROTAC degrader. ARD-266 effectively induces degradation of AR protein in AR -positive LNCaP, VCaP, and 22Rv1 prostate cancer cell lines with DC 50 values of 0.2-1 n.
Specifications and Purity: ≥99%
Molecular Formula: C52H59ClN6O7
Molecular Weight: 915.51
- UPC:
- 41113405
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- A658631-10mg
- Product Size:
- 10mg
akash.verma@cenmed.com
(732) 447-1115





